International | Germany
Strategy
Strategy

Biotest is one of the world’s leading specialists in immunology and hematology. We intend to strengthen this position in order to create the basis of solid profitable growth of the Biotest Group.
 
Our strategy rests on three pillars: Internationalisation, strengthening of our position as a high-quality supplier as well as research and development. In various projects and in production, we cooperate with strategic partners. Together with these partners we will reach higher goals more rapidly.
 
Biotest products have an important ethical significance. They are used in sensible clinical areas; they often save lives directly, or they serve as treatment of very severe chronic disease. This means a great responsibility, which we intend to assume. You will find more details about this in the column Values.
The Strategy of Biotest